loadpatents
name:-0.026273012161255
name:-0.025377988815308
name:-0.00080609321594238
Levin; Jeremy I. Patent Filings

Levin; Jeremy I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Levin; Jeremy I..The latest application filed is for "pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof".

Company Profile
0.21.19
  • Levin; Jeremy I. - New City NY
  • Levin; Jeremy I. - Nanuet NY
  • Levin; Jeremy I. - Spring Valley NY
  • Levin; Jeremy I. - Rockland NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase
Grant 7,595,327 - Levin , et al. September 29, 2
2009-09-29
Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
Grant 7,576,222 - Park , et al. August 18, 2
2009-08-18
Method for the treatment of polycystic kidney disease
Grant 7,488,754 - Frost , et al. February 10, 2
2009-02-10
Pyrazolo[1,5-A]pyrimidine derivatives and methods of use thereof
App 20070219186 - Gopalsamy; Ariamala ;   et al.
2007-09-20
Method for preparing hydroxamic acids
Grant 7,179,911 - Wang , et al. February 20, 2
2007-02-20
Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase
App 20060211730 - Levin; Jeremy I. ;   et al.
2006-09-21
Alkynyl-containing tryptophan derivative inhibitors of tace/matrix metalloproteinase
App 20060160884 - Park; Kaapjoo ;   et al.
2006-07-20
Method for preparing hydroxamic acids
App 20050272928 - Wang, Ting-Zhong ;   et al.
2005-12-08
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
Grant 6,946,473 - Levin , et al. September 20, 2
2005-09-20
Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
App 20050113346 - Levin, Jeremy I. ;   et al.
2005-05-26
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors
Grant 6,825,354 - Levin , et al. November 30, 2
2004-11-30
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/TACE inhibitors
App 20040229924 - Levin, Jeremy I. ;   et al.
2004-11-18
Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
Grant 6,812,227 - Levin , et al. November 2, 2
2004-11-02
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
Grant 6,762,178 - Levin , et al. July 13, 2
2004-07-13
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
Grant 6,753,337 - Levin , et al. June 22, 2
2004-06-22
Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
Grant 6,716,833 - Levin , et al. April 6, 2
2004-04-06
Method for the treatment of polycystic kidney disease
App 20040063672 - Frost, Philip ;   et al.
2004-04-01
Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
App 20040033988 - Levin, Jeremy I. ;   et al.
2004-02-19
Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
App 20030212049 - Levin, Jeremy I. ;   et al.
2003-11-13
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
App 20030208066 - Levin, Jeremy I.. ;   et al.
2003-11-06
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
Grant 6,534,491 - Levin , et al. March 18, 2
2003-03-18
Acetylenic alpha -amino acid-based sulfonamide hydroxamic acid tace inhibitors
App 20030008849 - Levin, Jeremy I. ;   et al.
2003-01-09
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
App 20020188132 - Levin, Jeremy I. ;   et al.
2002-12-12
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
App 20020147342 - Levin, Jeremy I. ;   et al.
2002-10-10
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
App 20020132826 - Levin, Jeremy I. ;   et al.
2002-09-19
Acetylenic sulfonamide thiol TACE inhibitors
App 20020103163 - Levin, Jeremy I. ;   et al.
2002-08-01
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
App 20020086890 - Levin, Jeremy I. ;   et al.
2002-07-04
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
Grant 6,340,691 - Levin , et al. January 22, 2
2002-01-22
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
App 20010056088 - Levin, Jeremy I. ;   et al.
2001-12-27
Acetylenic .beta.-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
Grant 6,326,516 - Levin , et al. December 4, 2
2001-12-04
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
App 20010046989 - Levin, Jeremy I. ;   et al.
2001-11-29
Acetylenic sulfonamide thiol tace inhibitors
Grant 6,313,123 - Levin , et al. November 6, 2
2001-11-06
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
App 20010025047 - Levin, Jeremy I. ;   et al.
2001-09-27
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
Grant 6,277,885 - Levin , et al. August 21, 2
2001-08-21
Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
Grant 6,225,311 - Levin , et al. May 1, 2
2001-05-01
Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
Grant 5,358,951 - Levin , et al. October 25, 1
1994-10-25
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
Grant 5,294,611 - Venkatesan , et al. March 15, 1
1994-03-15
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
Grant 5,290,780 - Venkatesan , et al. March 1, 1
1994-03-01
Benzoylaminoquinazolinones
Grant 5,084,457 - Fanshawe , et al. January 28, 1
1992-01-28
5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disorders
Grant 4,916,137 - Epstein , et al. April 10, 1
1990-04-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed